G35.A: Relapsing-remitting multiple sclerosis

New code · FY2026

Billable: use this code on claims.

• New code, effective October 1, 2025 (FY2026).

Code breakdown

Coding notes

Excludes1

• demyelinating disease of central nervous system, unspecified (G37.9)

Medicare coverage

G35.A is listed as a covered diagnosis in 61 Medicare billing and coding articles:

• A52996 Billing and Coding: Routine Foot Care
• A53060 Billing and Coding: Ophthalmology: Extended Ophthalmoscopy and Fundus Photography
• A54095 Billing and Coding: Nerve Conduction Studies and Electromyography
• A54969 Billing and Coding: Nerve Conduction Studies and Electromyography
• A55310 Billing and Coding: Instructions for Lemtrada® (alemtuzumab) When Used in the Treatment of Relapsing Multiple Sclerosis
• A55639 Billing and Coding: Chemotherapy Agents for Non-Oncologic Conditions
• A56232 Billing and Coding: Foot Care
• A56380 Billing and Coding: Rituximab
• A56551 Billing and Coding: Visual Fields Testing
• A56612 Billing and Coding: CT of the Head

…and 51 more. Check the coverage tool for your CPT code.

Check this code

• Code search: full entry and nearby codes
• Excludes checker: can it be billed with another code?
• Coverage checker: is it covered for your CPT code?

All FY2026 ICD-10-CM changes

ICD-10-CM codes and descriptions are from the CMS and NCHS code files. Coverage is from the CMS Medicare Coverage Database billing and coding articles.